HIMSS debuts mobile health roadmap

mHIMSS, the mobile initiative of the Health Information and Management Systems Society (HIMSS), has introduced the mHIMSS Roadmap to provide direction related to mobile health (mHealth).

HIMSS and mHIMSS members have access to all sections of this interactive tool that includes information on new care models, technology, return on investment and payment, policy, privacy and security, standards and interoperability. 

HIMSS introduced its mHIMSS initiative in December 2011, and now a group of industry experts created the roadmap to be a "living document" that will be updated to reflect new industry developments by a team of volunteers.

“We--the mHealth community--recognize the rapid change related to the use of mobile and mHealth devices and the need to empower the use of these devices in healthcare. Increasingly, patients and providers are leveraging mobile devices to seek care, participate in and deliver care,” says Mohamad Arif Ali, MD, chair of the mHIMSS Roadmap Task Force, in the Roadmap introduction. “Mobile devices represent the opportunity to interact and provide this care beyond the office walls. The HIMSS Roadmap combines up-to-date knowledge on how to implement mobile and mHealth best practices across a number of topics.”

Learn more about the mHIMSS Roadmap.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.